Madrigal Pharmaceuticals inc. buy BiotechBee
Start price
24.06.23
/
70%
€214.90
Target price
31.05.26
€380.00
Performance (%)
3.07%
Price
22.08.24
€224.00
Summary
This prediction is currently active. With a performance of 3.07%, the BUY prediction by BiotechBee for Madrigal Pharmaceuticals inc. is trending in the right direction. This prediction currently runs until 31.05.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Madrigal Pharmaceuticals inc. | -1.538% | -1.538% | 35.840% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% |
According to BiotechBee what are the pros and cons of Madrigal Pharmaceuticals inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Madrigal Pharmaceuticals inc. diskutieren
Buy mit Kursziel 380,0
Stopped prediction by BiotechBee for Madrigal Pharmaceuticals inc.
Madrigal Pharmaceuticals inc.
Start price
Target price
Perf. (%)
€66.50
30.09.22
30.09.22
€120.00
31.12.24
31.12.24
324.36%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year